Related Experiment Video
Updated: May 20, 2026
09:40
Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Phosphopeptide selective coordination complexes as promising SRC homology 2 domain mimetics
Joel A Drewry1, Eugenia Duodu, Amir Mazouchi
1Department of Chemical and Physical Sciences, University of Toronto, 3359 Mississauga Road North, Mississauga, Ontario L5L 1C6, Canada.
Inorganic Chemistry
|July 13, 2012
Summary
New coordination complexes mimic Src Homology 2 (SH2) domains to disrupt cancer-promoting interactions. These compounds show high affinity and selectivity, effectively reducing cancer cell viability in multiple tumor types.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Cancer Biology
Background:
- Src Homology 2 (SH2) domains are critical phosphotyrosine (pY) binding modules.
- Dysregulated pY-mediated protein-protein interactions are implicated in cancer progression.
- Targeting these interactions offers a therapeutic strategy for cancer treatment.
Purpose of the Study:
- To design and synthesize novel coordination complexes as SH2 domain proteomimetics.
- To achieve sequence-selective disruption of pY-mediated protein-protein interactions.
- To evaluate the anticancer efficacy of these compounds in various cancer cell lines.
Main Methods:
- Synthesis of a library of coordination complex SH2 domain proteomimetics.
- In vitro characterization of phosphopeptide binding affinity and selectivity.
- Biological screening for cytotoxicity in breast cancer, prostate cancer, and acute myeloid leukemia cell lines.
Main Results:
- Lead mimetics exhibited high phosphopeptide affinity (K(a) ~ 10(7) M(-1)) and selectivity.
- Compounds demonstrated sequence-selective discrimination through a two-point binding mode.
- Several compounds potently disrupted cancer cell viability across different cancer types.
Conclusions:
- Coordination complexes can effectively mimic SH2 domains for targeted cancer therapy.
- The developed proteomimetics show promise as novel anticancer agents.
- Further investigation into these compounds could lead to new therapeutic strategies for various cancers.
Related Concept Videos
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
02:26Conservation of Protein Domains Over Different Proteins
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: